Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis
Year: 2006
Type: article
Abstract: Tyrosine kinases play a central role in the activation of signal transduction pathways and cellular responses that mediate the pathogenesis of rheumatoid arthritis. Imatinib mesylate (imatinib) is a tyrosine kinase inhibitor developed to treat Bcr/Abl-expressing leukemias and subsequently found to treat c-Kit-expressing gastrointestinal stromal tumors. We demonstrate that imatinib potently prevents and treats murine collagen-induced arthritis (CIA). We further show that micromolar concentrations of imatinib abrogate multiple signal transduction pathways implicated in RA pathogenesis, including mast cell c-Kit signaling and TNF-alpha release, macrophage c-Fms activation and cytokine production, and fibroblast PDGFR signaling and proliferation. In our studies, imatinib attenuated PDGFR signaling in fibroblast-like synoviocytes (FLSs) and TNF-alpha production in synovial fluid mononuclear cells (SFMCs) derived from human RA patients. Imatinib-mediated inhibition of a spectrum of signal transduction pathways and the downstream pathogenic cellular responses may provide a powerful approach to treat RA and other inflammatory diseases.
DOI: 10.1172/jci28546
Authors: R. T. Paniagua, O. Sharpe, P. P. Ho, S. M. Chan, A. Chang, J. P. Higgins, B. H. Tomooka, F. M. Thomas, J. J. Song, S. B. Goodman, D. M. Lee, M. C. Genovese, P. J. Utz, L. Steinman, W. H. Robinson
Institutions: Stanford Medicine, Stanford University, Harvard University
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: U.S. Department of Veterans Affairs, Dana Foundation, Memorial Sloan-Kettering Cancer Center, Multiple Sclerosis Society, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Awards: Multiplex Autoantibody Profiling in SLE, G1898635787, G465681081, DNA VACCINE MEDIATED IMMUNOTHERAPY OF RHEUMATIC DISEASE, NHLBI PROTEOMICS INITIATIVE, Tyrosine Kinase Pathways in Rheumatoid Arthritis, Autoantigen Arrays to Select Vaccines for Model of PBC, G9000139216, Molecular and Cellular Immunobiology
OpenAlex ID: W2141138459
